HMG

HMG (human menopausal gonadotropin) is a research-grade injectable gonadotropin preparation containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity, used in experimental models of reproductive endocrinology and fertility regulation. It is typically studied for its effects on ovarian follicle development, spermatogenesis, and sex-steroid production within hypothalamic–pituitary–gonadal axis research contexts.

Theoretical Research Benefits

• Reproductive hormone stimulation: Provides exogenous FSH/LH activity to model controlled ovarian hyperstimulation, follicular maturation, ovulation induction, and testicular steroidogenesis in fertility and hypogonadism simulations.

• Gametogenesis support: Enables investigation of oocyte quality, embryo yield, and sperm production parameters by directly driving gonadal response in assisted reproduction and basic reproductive biology studies.

• Endocrine axis modeling: Useful for dissecting feedback mechanisms between gonads, pituitary, and hypothalamus, including changes in estradiol, progesterone, and testosterone profiles across experimental protocols.

For research purposes only. Not intended for human consumption, medical treatment, or veterinary use.